Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

AIMday in Healthy Ageing - registration for academics now open

General

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Healthy Ageing.

Networking events, like AIMdays, are one of the ways in which we bring together innovative companies and world-leading academics.

The University of Oxford, together with the UK SPINE Knowledge Exchange, will be hosting an AIMday in Healthy Ageing on Wednesday 9 October 2019 at Blavatnik School of Government. This event will bring together industry with academia to discuss the healthcare challenges associated with ageing. The UK Spine initiative aims to accelerate innovations in ageing and the AIMday will draw on expertise from all the UK Spine’s partners: the University of Oxford, the University of Dundee, the University of Birmingham, the Medicines Discovery Catapult and the Francis Crick Institute.

FREE registration for academics is now open and closes on Friday 27 September (advance registration is essential).

A range of companies including Five Alarm Bio, Isansys, Kemuri, Shift Bioscience (& more) are registered to attend the event and it will be a fantastic opportunity for researchers looking to network with industry and discuss relevant questions.

To see the questions posed by these companies, please visit aimday.se/healthy-ageing-oxford-2019/questions-listing.

Register here: aimday.se/healthy-ageing-oxford-2019/registration-for-researchers

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

COVID winter plan: UK blueprint doesn’t go far enough – here’s a health expert’s alternative

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.